Patients’ Perspectives on the Development of Prescription Opioid Use Disorder in Patients with Chronic Non-Cancer Pain

• Published in: European addiction research Vol. 29; no. 2; pp. 141 - 149
• Main Authors: Davies, Lisa E.M., Koster, Ellen S., Damen, Katinka F.M., Beurmanjer, Harmen, Schellekens, Arnt F.A., Bouvy, Marcel L.
• Format: Journal Article
• Language: English
• Published: Basel, Switzerland 01.06.2023
• Subjects: Research Article; Qualitative research; Abuse of prescription drugs; Opioid dependency; Opioid use disorder; Opiate addiction; Prescription opioid dependency
• ISSN: 1022-6877; 1421-9891
• DOI: 10.1159/000529926

Abstract Introduction: In the past decade, prescription opioid use increased exponentially and concomitantly opioid use disorders (OUD) are becoming more common. Several risk factors for developing OUD have been identified, but little is known regarding the patients’ perspective on developing a prescription OUD. Methods: We recruited 25 adults undergoing treatment for prescription OUD. In-depth, semi-structured interviews focussed on experiences with long-term opioid use, knowledge and attitudes regarding opioids, and access to opioids. A directed content analysis was conducted on the transcribed interviews using NVivo. Results: Participants showed that the development of an OUD is affected by various factors which could be grouped into three themes: (1) experiences driving initiation, (2) experiences driving continuation, and (3) experiences with prescription OUD. Besides the need for pain management, the dynamics of patient-provider communication, care coordination, provider vigilance, and environmental support all contributed to the way patients used their opioids. Conclusion: Patients’ experiences illustrate that the first stage of the development of prescription OUD differs from the development of other substance addictions. Negative reinforcement might play a more prominent role in the early phase of prescription opioid use. Patients expressed a lack of guidance, both at the start of use and long-term use, easy access to new prescriptions and a lack of monitoring as main drivers of the development. Poorly controlled pain and subjective stress fuelled continuous opioid use.